2.35m, page-2

CARDIA TO RAISE $2.35M:
RENOUNCEABLE RIGHTS ISSUE & APPENDIX 3B
Cardia Bioplastics Limited (CNN) announces a rights issue to raise up to $2.35m .The issue is
proposed to be underwritten up to $1.5m by Patersons Securities Limited. The funds will be
used for working capital purposes in order to address the Company’s immediate sales
opportunities along with funding the Company’s development projects as the bioplastics
business gains sales momentum.
Details are as follows.
The Board of Cardia Bioplastics Limited (“the Company”) announces a renounceable rights issue to
eligible shareholders on the following terms (“Rights Issue”):
? One (1) new ordinary fully paid share (“New Share”) for every four (4) shares held at the
Record Date, at an issue price of $0.007 per new share.
? For every one New Share subscribed, one (1) option exercisable at $0.015 each at any time
up to 5pm AEST on 30 June 2015 (“Expiry Date”) will be issued to the subscriber at nil cost.
? The Rights Issue is expected to raise approximately $2.35M before expenses.
? Patersons Securities Limited is the Lead Manager and underwriter to the Rights Issue which
is proposed to be underwritten up to $1.5 million.
? The New Shares will rank pari passu with the existing issued shares of the Company.
? The Issue will round down.
? The maximum number of shares offered under the Rights Issue Offer is 336,351,454
(assuming no existing options are exercised prior to the Record Date).
? The maximum number of New Options offered under the Rights Issue Offer is 336,351,454.
An Appendix